Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Change in Cash (2016 - 2025)

Historic Change in Cash for Apyx Medical (APYX) over the last 15 years, with Q3 2025 value amounting to -$4.2 million.

  • Apyx Medical's Change in Cash rose 1069.67% to -$4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.9 million, marking a year-over-year decrease of 14895.39%. This contributed to the annual value of -$11.9 million for FY2024, which is 13559.77% down from last year.
  • Per Apyx Medical's latest filing, its Change in Cash stood at -$4.2 million for Q3 2025, which was up 1069.67% from -$1.7 million recorded in Q2 2025.
  • Apyx Medical's Change in Cash's 5-year high stood at $21.5 million during Q4 2023, with a 5-year trough of -$6.4 million in Q1 2024.
  • Its 5-year average for Change in Cash is -$883157.9, with a median of -$3.8 million in 2021.
  • Per our database at Business Quant, Apyx Medical's Change in Cash tumbled by 1647500.0% in 2022 and then surged by 56365.01% in 2023.
  • Over the past 5 years, Apyx Medical's Change in Cash (Quarter) stood at -$28000.0 in 2021, then plummeted by 16475.0% to -$4.6 million in 2022, then skyrocketed by 563.65% to $21.5 million in 2023, then crashed by 82.67% to $3.7 million in 2024, then crashed by 211.75% to -$4.2 million in 2025.
  • Its last three reported values are -$4.2 million in Q3 2025, -$1.7 million for Q2 2025, and -$730000.0 during Q1 2025.